| scholarly article | Q13442814 |
| P50 | author | Yawara Kawano | Q84529928 |
| P2093 | author name string | Eri Fujii | |
| Hiroyuki Hata | |||
| Yutaka Okuno | |||
| Naoko Wada | |||
| Shiho Fujiwara | |||
| Shinya Endo | |||
| Yuki Inada | |||
| Nao Nishimura | |||
| Misaki Kakoki | |||
| Toshiya Sugimoto | |||
| P2860 | cites work | Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma | Q28077635 |
| Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research | Q28484427 | ||
| Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties | Q34117287 | ||
| Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking | Q34162874 | ||
| Bufalin induces cell death in human lung cancer cells through disruption of DNA damage response pathways | Q34421829 | ||
| A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice | Q36086031 | ||
| Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance | Q37005088 | ||
| Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway | Q37190269 | ||
| Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma | Q37565283 | ||
| Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment | Q37702160 | ||
| Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy | Q37723274 | ||
| Hypoxia and hypoxia inducible factors in cancer stem cell maintenance | Q37768064 | ||
| Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche | Q37777514 | ||
| Targeting the bone marrow microenvironment in multiple myeloma. | Q38289041 | ||
| Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma. | Q38305518 | ||
| Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1α. | Q38754838 | ||
| Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma | Q38755819 | ||
| Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo | Q38756541 | ||
| Implications of Oxygen Homeostasis for Tumor Biology and Treatment. | Q38876568 | ||
| Microenvironment drug resistance in multiple myeloma: emerging new players | Q38913083 | ||
| Modulating tumor hypoxia by nanomedicine for effective cancer therapy | Q38961080 | ||
| Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells | Q39078376 | ||
| Cardiac glycosides block cancer growth through HIF-1α- and NF-κB-mediated Plk1 | Q39161209 | ||
| Bufalin alters gene expressions associated DNA damage, cell cycle, and apoptosis in human lung cancer NCI-H460 cells in vitro. | Q39192639 | ||
| Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan | Q39813872 | ||
| Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells | Q42413385 | ||
| Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). | Q42813868 | ||
| Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells | Q42838383 | ||
| Bufalin influences the repair of X-ray-induced DNA breaks in Chinese hamster cells. | Q44671716 | ||
| Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma | Q53067116 | ||
| Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers | Q53083871 | ||
| Purification and characterization of IgE produced by human myeloma cell line, U266 | Q69497644 | ||
| Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer | Q83371465 | ||
| P433 | issue | 5 | |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 6443-6449 | |
| P577 | publication date | 2018-02-21 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Bufalin induces DNA damage response under hypoxic condition in myeloma cells | |
| P478 | volume | 15 |
Search more.